-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

ASH Poster Walk on What's New in Complement-Related Diseases? Hosted by Blood Red Cells & Iron (For In-person Participants)

Program: ASH Poster Walks
Hematology Disease Topics & Pathways:
Research, Fundamental Science, Clinical trials, Adult, Translational Research, Clinical Research, Pediatric, Patient-reported outcomes, Real-world evidence, Registries, Adverse Events, Study Population, Human
Sunday, December 8, 2024: 11:15 AM-12:15 PM
Halls G-H - Blood Journals Studio (San Diego Convention Center)
Complement-related diseases in relevance to the hematologist traditionally include paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS). Nevertheless, novel developments have implicated complement activation in a number of disorders that are relevant to hematologists, including hematopoietic stem cell transplantation thrombotic microangiopathy (HSCT-TMA), delayed hemolytic transfusion reaction (DHTR) and other complications of sickle cell disease, antiphospholipid antibody syndrome, and HELLP syndrome. 

This Poster Walk will feature abstracts on complement activation and inhibition and foster collaborations amongst researchers and physicians looking to identify novel inhibitors and therapeutics in this area. 

Join us in the Blood Studio located in the main Poster Hall for this in-person poster walk hosted by ASH’s Blood Red Cells & Iron journal.

Alexander Röth, MD1, Wilma Barcellini, MD2*, Christine Ademokun3*, Shripad Chitnis4*, Sofiya Matviykiv5*, Alessandra Vitaliti5*, Chi Chen6*, Vasiliki Katsanou5*, Raghav Chawla, MD, PhD5 and Hanny Al-Samkari, MD7

1Department of Hematology and Stem Cell Transplantation, West German Cancer Center, University Hospital Essen, University Duisburg-Essen, Essen, Germany
2Department of Hematology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
3Imperial College Healthcare NHS Trust, London, United Kingdom
4Novartis Biomedical Research, Cambridge, MA
5Novartis BioMedical Research, Basel, Switzerland
6China Novartis Institutes for BioMedical Research Co Ltd, Shanghai, China
7Division of Hematology, Massachusetts General Hospital, Harvard Medical School, Boston, MA

Michelle L Schoettler, MD1*, Jayre Jones2*, William Briones, BS3*, Elyse Bryson, PA4*, Muna Qayed, MD5, Seema R Patel, PhD6, Katherine Silvis7*, Adrianna Westbrook8*, Kirsten M. Williams, MD9 and Satheesh Chonat, MD10

1Emory University, Children’s Healthcare of Atlanta, Aflac Cancer and Blood Disorders Center, Atlanta, GA
2Emory University School of Medicine, Atlanta, GA
3Aflac Cancer and Blood Disorders, Children's Healthcare of Atlanta, Emory University, Atlanta, GA
4Children's Healthcare of Atlanta, Atlanta, GA
5Division of Pediatric Hematology, Oncology and Bone Marrow Transplantation, Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Atlanta, GA
6Aflac Cancer and Blood Disorders Center, Emory University and Children's Healthcare of Atlanta, Atlanta, GA
7Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta and, Atlanta, GA
8Emory University Hospital, Atlanta, GA
9Aflac Cancer and Blood Disorders Center, Children's Healthcare of Atlanta, Emory University, Atlanta, GA
10Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, Emory University Department of Pediatrics, Atlanta, GA

Bruno Fattizzo, MD1, Anna Paola Iori2*, Antonio De Vivo, MD3*, Elisabetta Metafuni4*, Amalia Figuera, MD5*, Luana Marano, MD6*, Esther Natalie Oliva, MD7*, Maria Bruna Greve8*, Francesco Lanza, MD9*, Eros Di Bona, MD10*, Jacopo Micozzi, MD11*, Giovanni Caocci, MD12, Francesca Fioritoni13*, Fabio Ciceri, MD14*, Angela Amendola15*, Carmine Selleri, MD16, Francesco Longu17*, Alessandra Tucci, MD18, Eloise Beggiato, MD19*, Davide Rapezzi, MD20*, Alessandro Cignetti21*, Tiziana Anna Urbano22*, Nicola Di Renzo23*, Valeria Amico, MD24*, Pierangelo Spedini25*, Alessandro Rambaldi26,27, Simona Raso, MD28*, Cristina Clissa, MD29*, Sergio Cabibbo30*, Barbara Roncari31*, Lucia Simoni31*, Benedetta Campolo32*, Fabio Carini33*, Davide Mattiuzzi33* and Wilma Barcellini, MD34*

1Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano, Italy
2Department of Translational and Precision Medicine, Policlinico Umberto I Hospital, Sapienza University of Rome, Roma, Roma, ITA
3Institute Of Hematology, Bologna, Italy
4Hematology Unit, Università Cattolica Del Sacro Cuore, Rome, ITA
5Hematology and Bone Marrow Transplatation Unit, A.O.U. Policlinico “G. Rodolico - S.Marco", Catania, 95123, ITA
6Hematology and BMT Unit, AORN San Giuseppe Moscati, Avellino, Italy
7Hematology, Melacrino Morelli Hospital, Reggio Calabria, AL, Italy
8Grande Ospedale Metropolitano di Reggio Calabria - Melacrino Morelli, Reggio Calabria, Italy
9Division of Hematology, Onco-hematologic Department, AUSL della Romagna, Ravenna, Italy
10UOC Oncoematologia, AULSS7 Pedemontana, Bassano del Grappa (VI), Vicenza, Italy
11Division of Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Policlinico Umberto I, Sapienza University of Rome, Rome, Italy
12University of Cagliari, Monserrato, Italy
13Department of Haematology, Pescara, ITA
14Hematology and Bone Marrow Transplantation Unit, I.R.C.C.S. San Raffaele Scientific Institute, Milan, Italy
15Ematologia, AOR San Carlo, Potenza, Potenza, ITA
16Hematology and Transplant Center, University Hospital “San Giovanni di Dio e Ruggi d’Aragona”, Salerno, Italy
17University of Sassari, Sassari, Missouri, ITA
18Department of Hematology, ASST Spedali Civili di Brescia, Brescia, Italy
19Hematology, AOU Città della Salute e della Scienza di Torino-Presidio Ospedaliero Molinette, Turin, Italy
20Department of Hematology, S. Croce e Carle Hospital, Cuneo, Italy
21University Division of Hematology and Cell Therapy, A.O. Ordine Mauriziano, Turi, Torino, ITA
22U.O. Ematologia Ospedale “S. Giuseppe Moscati”, Taranto, ASL TA1, Taranto, ITA
23"Vito Fazzi" Hospital, Hematology and Stem Cell Transplant Unit, Lecce, Italy
24Immunoematologia e Trasfusione Azienda Ospedaliera “San Pio”, Benevento, Italy, benevento, Italy
25ASST Cremona, Ematologia, Cremona, ITA
26UO Ematologia, ASST Papa Giovanni XXIII, Bergamo, Italy
27Department of Oncology-Hematology, Azienda Socio-Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy
28Department of Hematology and Rare Diseases, Azienda Ospedaliera Ospedali Riuniti Villa Sofia-Cervello, Palermo, Italy
29Department of Medicine, Section of Hematology, University of Verona, Verona, Italy
30ASP Ragusa- P.O. Giovanni Paolo II Ematologia, Ragusa, Italy
31IQVIA, Milano, Italy
32Alexion AstraZeneca Rare Disease, Milan, ITA
33Alexion Astrazeneca Rare Disease, Milano, Italy
34Hematology Unit, Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, Milan, Italy

Michael Daunov, DO1, John Sumodi2*, Nikki Agarwal, MD1*, Molly Megan Gallogly, MD, PhD1,3, Leland Metheny, MD1,3, Ben K. Tomlinson, MD1,3, Rebecca B. Klisovic, MD1,4, Ali W. Bseiso, MD1*, Brett Glotzbecker, MD1*, Kord Honda5* and Koen van Besien, MD, PhD1,3

1Department of Hematology and Stem Cell Transplant, University Hospitals Seidman Cancer Center, Cleveland, OH
2Department of Pathology, University Hospitals Cleveland Medical Center, Cleveland, OH
3Case Comprehensive Cancer Center, Case Western Reserve University, Cleveland, OH
4Case Western Reserve University, Cleveland, OH
5Department of Dermatopathology, University Hospitals, Cleveland, OH

Moritz Saxenhofer, PhD1,2*, Mattheus Wildschut2,3*, Carlos Perez Roca2,3*, Gregory J. Kato4, Justine Brodard5*, Christelle Chirlias6*, Linet Njue5*, Ioannis Chanias5*, Ana Batista Mesquita Sauvage6*, Cesare Medri5*, Gerasimos Tsilimidos6*, Lucas Veuthey6*, Anna Schnell2,3*, Stefanie Graeter2,3*, Jacqueline Adam2,3*, Thomas Gentinetta2,3*, Sandra Mena Perez2,3*, Daniel Couto2,3*, Nicole Hadorn5*, Mila Keiser5*, Alan G. Haynes7*, Kathrin Bieri7*, Lorenzo Alberio6*, Francesco Grandoni6*, Ramona Merki8*, Emmanuel Levrat9*, Kaveh Samii10*, Anne Angelillo-Scherrer5, Alexander Schaub2,3*, Mathilde Gavillet, MD, PhD11* and Alicia Rovó5

1CSL Behring, Bern, AL, Switzerland
2Swiss Institute for Translational and Entrepreneurial Medicine, sitem-insel, Bern, Switzerland
3CSL Behring, Bern, Switzerland
4CSL Behring, King of Prussia, PA
5Inselspital, Bern University Hospital, Bern, Switzerland
6Lausanne University Hospital (CHUV), Lausanne, Switzerland
7University of Bern, Bern, Switzerland
8Aarau Cantonal Hospital, Aarau, Switzerland
9Hôpital Cantonal Fribourg, Fribourg, Switzerland
10Geneva University Hospitals (HUG), Geneva, Switzerland
11Service and Central Laboratory of Hematology, Department of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland

Maria Queralt Salas, MD1*, Julia Martinez-Sanchez, PhD2*, Raquel Salinas González, MD3*, Blanca de Moner4*, ANA Belen MORENO Castaño, MD5*, Silvia Escribano-Serrat, MD5*, Alex Ramos6*, Carla Mestre7*, Cristina Padilla8*, Laia Guardia9*, Filipe Pinto, MD9*, Paola Charry, MD10*, Joan Cid, MD PhD11*, Miquel Lozano, MD, PhD12*, Enric Cascos, MD13*, Jordi Esteve, MD, PhD14, Sara Laxe, MD15*, Concepción Closa, MD15*, Enric Carreras, MD, PhD16*, Maria Suarez-Lledo, MD, PhD17*, Laura Rosiñol Dachs, MD PhD18*, Francesc Fernández-Avilés, MD, PhD19*, Montserrat Rovira, MD, PhD19*, Maria Carmen Martinez Munoz, MD, PhD20* and Maribel Diaz-Ricart, PhD2*

1Hematopoietic Transplantation Unit, Hospital Clinic de Barcelona, ICAMS, Barcelona, Spain
2Hemostasis and Erythropathology, Hematopathology, Pathology Department, CDB, IDIBAPS, University of Barcelona, Hospital Clínic de Barcelona, Barcelona, Spain
3Physical Medicine and Rehabilitation Department, Hospital Clinic de Barcelona, Barcelona, Spain
4Hospital Clinic de Barcelona, Ba, Spain
5Hospital Clinic Barcelona, Barcelona, Spain
6Institut d’Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS. Hospital Clinic de Barcelona, Barcelona, Spain
7Endocrinology and Nutrition Department, Hospital Clinic of Barcelona, Barcelona, Spain
8Hospital Clinic of Barcelona, Barcelona, ESP
9Hematopoietic Transplantation Unit, Hematology Department, Clinical Institute of Hematology and Oncology (ICMHO), Hospital Clinic de Barcelona, Barcelona, Spain
10Apheresis and Cellular Therapy Unit, Hemotherapy and Hemostasis Department, Clinical Institute of Hematology and Oncology (ICMHO), Hospital Clinic de Barcelona, Barcelona, Spain
11Hospital Clinic, University of Barcelona, Barcelona, Spain
12Apheresis and Cellular Therapy Unit, Hemotherapy and Hemostasis Department, Clinical Institute of Hematology and Oncology (ICMHO), Hospital Clínic de Barcelona, Barcelona, Spain
13Cardiology Department, Hospital Clinic de Barcelona, Barcelona, Spain
14Hematology Department, Hospital Clínic Barcelona, ICAMS, Barcelona, Spain
15Physical Medicine and Rehabilitation Department, Hospital Clinic of Barcelona, Barcelona, Spain
16Fundació Josep Carreras Contra la Leucèmia, Barcelona, Spain
17Hematopoietic Transplantation Unit, Hematology Department, Clinical Institute of Hematology and Oncology (ICMHO), Spain, Hospital Clínic de Barcelona, Barcelona, Spain
18Hematopoietic Cell Transplant Unit, Hospital Clínic de Barcelona, ICAMS, Barcelona, Spain
19Hematopoietic Transplantation Unit, Hematology Department, Clinical Institute of Hematology and Oncology (ICMHO), Hospital Clínic de Barcelona, Barcelona, Spain
20Hematopoietic Cell Transplant Unit, Hospital Clinic of Barcelona, ICAMS, Barcelona, Spain

See more of: ASH Poster Walks